This process enhances the activation of effector CD4+ and CD8+ T cells in both the TDLNs and the tumour, as well as increases leukocyte infiltration and the proportion of IFN-γ and Granzyme B-producing CD8+ T cells in the tumour. This evidence concerns the gene CD4 and neoplasm.